The evaluation of antimicrobial susceptibility of urine enterococci with the Vitek 2 automated system in Eastern Turkey

Basit Öğe Kaydı
dc.authorscopusid36699336300
dc.authorscopusid55479335400
dc.authorscopusid55455473900
dc.contributor.authorSibel A.K.
dc.contributor.authorMehmet K.
dc.contributor.authorMuharrem A.K.
dc.date.accessioned2024-08-04T19:59:15Z
dc.date.available2024-08-04T19:59:15Z
dc.date.issued2012
dc.departmentİnönü Üniversitesien_US
dc.description.abstractAntibiotic resistant enterococci are an emerging problem, especially in urinary tract infections. The aim of the present study was to evaluate the antimicrobial susceptibility of 118 enterococci isolates from urine samples of patients admitted to Malatya State Hospital, a secondary care hospital in eastern Turkey. The Vitek 2 automated sytem was used to identify the bacteria and detect antimicrobial susceptibility to ten antibiotics: ampicillin, imipenem, ciprofloxacin, moxifloxacin, quinupristin-dalfopristin, tetracycline, tigecyclin, linezolid, vancomycin, teicoplanin and high level aminoglycoside resistance (HLAR) against kanamycin, gentamicin and streptomycin. The predominant species was Enterococci faecalis (74.5%) followed by Enterococcus faecium (18.6%). The resistance rates for Enterococcus faecalis and E. faecium, were 54.5%/77.2% for ampicillin, 0/77.2% for imipenem, 18.1%/72.7% for both ciprofloxacin and moxifloxacin, 10.2%/9.1% for linezolid and 65.1%/5.2% for quinopristine-dalfopristin, respectively. Beta-lactamase production was detected in 54.5% of E. faecalis isolates. HLAR was also found in 54.5% of E. faecalis isolates and 36.3% of E. faecium isolates; kanamycin resistance comprised the highest proportions (39.7% and 9.1%) of these resistance rates. Five strains were resistant to and one had intermediate resistant to vancomycin. The highest resistance rates were against ampicillin, ciprofloxacin, moxifloxacin and tetracycline. Of the antimicrobial agents evaluated, vancomycin, teicoplanin and tigecycline had the lowest resistance rates.en_US
dc.identifier.endpage991en_US
dc.identifier.issn0125-1562
dc.identifier.issue4en_US
dc.identifier.pmid23077822en_US
dc.identifier.scopus2-s2.0-84868608762en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage986en_US
dc.identifier.urihttps://hdl.handle.net/11616/90498
dc.identifier.volume43en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSEAMEO TROPMED Networken_US
dc.relation.ispartofSoutheast Asian Journal of Tropical Medicine and Public Healthen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAntimicrobial susceptibilityen_US
dc.subjectEnterococcus sppen_US
dc.subjectHLARen_US
dc.subjectUrinary tract infectionen_US
dc.subjectVitek 2en_US
dc.titleThe evaluation of antimicrobial susceptibility of urine enterococci with the Vitek 2 automated system in Eastern Turkeyen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu